Executives On The Move: Change At The Top For Endo And Santen, And Corporate Restructuring At Sanofi
Executive Summary
Generics and specialty pharma Endo International and Japanese ophthalmic product company Santen Pharmaceutical each announce a new CEO. Meanwhile, restructuring at Sanofi results in departures of Chief Digital and Medical Officer, and EVPs of Primary Care, Business Transformation and External Affairs.